DMTHF-Tc
DMTHF-Tc (5N,10N-dimethyl tetrahydrofolic acid) is a radiopharmaceutical which combines DMTHF, a modified folate, with technetium-99m (99mTc), a gamma emitting radionuclide, in a chelate conjugate. It shows selectivity for certain cancer cells which overexpress FR-α, and can therefore be used for diagnostic imaging in nuclear medicine. DMTHF-Tc was developed by the Philip Low lab at Purdue University.
primaryTopic
DMTHF-Tc
DMTHF-Tc (5N,10N-dimethyl tetrahydrofolic acid) is a radiopharmaceutical which combines DMTHF, a modified folate, with technetium-99m (99mTc), a gamma emitting radionuclide, in a chelate conjugate. It shows selectivity for certain cancer cells which overexpress FR-α, and can therefore be used for diagnostic imaging in nuclear medicine. DMTHF-Tc was developed by the Philip Low lab at Purdue University.
has abstract
DMTHF-Tc (5N,10N-dimethyl tetr ...... d tissue for folate targeting.
@en
Wikipage page ID
42,869,400
page length (characters) of wiki page
Wikipage revision ID
1,023,001,340
Link from a Wikipage to another Wikipage
wikiPageUsesTemplate
subject
hypernym
type
comment
DMTHF-Tc (5N,10N-dimethyl tetr ...... Low lab at Purdue University.
@en
label
DMTHF-Tc
@en